Agilent Completes the InfinityLab Bio LC Portfolio
22 June 2021 - 5:00PM
Business Wire
Launching the full range for biopharma analysis at the Agilent
InfinityLab LC Virtual Conference
Agilent Technologies Inc. (NYSE: A) today announced the launch
of three InfinityLab Bio LC systems specifically developed to meet
the needs of the biopharma industry. The release is central to the
Agilent portfolio of complete Bio LC solutions, featuring
instruments, columns, and supplies that seamlessly integrate with
Agilent OpenLab and MassHunter software, and CrossLab services to
maximize efficiency in biopharma labs.
The three new systems include the 1290 Infinity II Bio LC System
with High-Speed Pump, the 1290 Infinity II Bio LC System with
Flexible Pump, and the 1260 Infinity II Prime Bio LC System. These
systems are based on the proven, award-winning InfinityLab LC
technology and were designed to help future-proof laboratories by
providing a universal LC platform that delivers InfinityLab LC
reliability and performance with additional bio-analysis capability
and even greater resistance to harsh analytical conditions.
"This is a significant portfolio release that further
demonstrates Agilent's commitment to the fast-growing biopharma LC
market," said Stefan Schuette, vice president, and general manager
of Agilent’s Liquid Phase Separations Division. "By offering new
instruments, columns, application kits, and supplies we're
providing solutions that customers can tailor to meet their
specific bio-analytical requirements, including seamless transfer
of existing methods from both Agilent and non-Agilent LC
systems.”
Agilent also announced the planned release of several new
workflow solutions based on the Bio LC core systems. These
specialized solutions include a new, biocompatible 2D-LC, method
development, and a new Online LC solution for process monitoring
and process analytical technology (PAT). These new solutions will
complement already existing bio-analytical LC/Q-TOF MS, SEC (Size
Exclusion Chromatography) and bio-purification solutions from
Agilent.
The Bio LC portfolio launch takes center stage at the first
InfinityLab LC Virtual Conference taking place on 22nd – 23rd June
2021. For more information, visit the event registration page.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics, and applied chemical markets, delivering
insight and innovation toward improving the quality of life.
Agilent instruments, software, services, solutions, and people
provide trusted answers to customers' most challenging questions.
The company generated revenue of $5.34 billion in fiscal year 2020
and employs 16,400 people worldwide. Information about Agilent is
available at www.agilent.com. To receive the latest Agilent news,
subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn,
Twitter, and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210622005072/en/
Catherine Kaye Agilent Technologies 07775 410632
catherine.kaye@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2024 to May 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From May 2023 to May 2024